{"data":{"id":"us/21-cfr-357.801","jurisdiction":"us","citation":"21 CFR 357.801","heading":"Scope.","body":"(a) An over-the-counter deodorant drug product for internal use in a form suitable for oral administration is generally recognized as safe and effective and is not misbranded if it meets each condition in this subpart and each general condition established in § 330.1 of this chapter.\n(b) References in this subpart to regulatory sections of the Code of Federal Regulations are to chapter I of title 21 unless otherwise noted.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER D—DRUGS FOR HUMAN USE","PART 357—MISCELLANEOUS INTERNAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE","Subpart I—Deodorant Drug Products for Internal Use"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"bd2e5d53e388715af88b665c8f0686750bf5c11490d9ed8f4a4d8c446759ec84","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-357.280","next":"us/21-cfr-357.803"},"notice":"GroundRules: Original legal text. Not legal advice."}